Necrotizing Enterocolitis in Infants With Congenital Heart Disease: The Role of Red Blood Cell Transfusions
In the preterm population, transfusion of red blood cells (RBCs) and use of RBCs with longer storage time have been independently associated with the development of NEC.
Comparison of Low Molecular Weight Hydroxyethyl Starch and Human Albumin as Priming Solutions in Children undergoing Cardiac Surgery
Human albumin is the conventional cardiopulmonary bypass circuit primer.
A Need for Speed? Bypass Time and Outcomes after Isolated Aortic Valve Replacement Surgery
Despite improvements over time with regard to morbidity, mortality and long-term survival, CPB time remains a significant factor determining mediastinal blood loss, ICU and hospital length of stay, and in-hospital mortality.
Congenital Anomalies of the Aortic Arch in Acute Type-A Aortic Dissection: Implications for Monitoring, Perfusion Strategy, and Surgical Repair
To assess whether management of acute Stanford type-A aortic dissection differs in patients with congenital anomalies of the aortic arch compared with standard institutional practice.
The Role of Patient’s Profile and Allogeneic Blood Transfusion in Development of Post-Cardiac Surgery Infections: A Retrospective Study
Our data showed that post-cardiac surgery infections occur more frequently in patients with predetermined risk factors.
Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation following Complex Heart Surgery
We investigated the influence of 6% hydroxyethyl starch (HES) 130/0.4 on coagulation and inflammation compared with albumin
Thromboelastography (TEG)-Based Algorithm Reduces Blood Product Utilization in Patients undergoing VAD Implant
Our results show that the strict use of a TEG-guided algorithm significantly reduces the consumption of blood products in patients undergoing VAD implant
A Multicenter Study of Primary Graft Failure after iInfant Heart Transplantation: Impact of Extracorporeal Membrane Oxygenation on Outcomes
Primary graft failure is the major cause of mortality in infant HTx. The aim of this study was to characterize the indication and outcomes of infants requiring ECMO support due to primary graft failure after HTx.
A Synopsis of 2007 ACCM Clinical Practice Parameters for Hemodynamic Support of Term Newborn and Infant Septic Shock
The search was narrowed to identify studies specifically relevant to term newborns, infants, and children. "Best Practice Outcomes" were identified and described clinical practice in these centers was used as a model. The new taskforce is presently working on updating new guidelines evaluating the literature of the past 6 years.
A factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Currently used anticoagulants prevent thrombosis but increase bleeding. We show an anticoagulation therapy without bleeding risk based on a plasma protease factor XII function-neutralizing antibody.
The Effect of Platelet-Rich Plasma (PRP) on Composite Graft Survival
As platelet-rich plasma (PRP) contains large numbers of growth factors and has been widely used for tissue regeneration, this study aimed to study PRP as an adjuvant to enhance composite graft survival.
Blood Conservation: What is Current Blood Draw Practice
The new AABB guidelines for red blood cell transfusions narrow the threshold for transfusion.